Covid pills are here, but they aren't for everyone. Find out if you should take this medicationThe pills have to be started as soon as possible, within five days of the start of symptoms.
27 Apr, 2022, 08.21 AM IST
How does Merck's COVID-19 pill compare to Pfizer's?Merck in November said its full trial results showed that molnupiravir lowered the chance of hospitalization or death by about 30% in patie...
31 Jan, 2022, 04.45 PM IST
SEC no to clinical trial waiver for Pfizer's Covid pillThe SEC asked the companies to conduct bioavailability and bioequivalence (BA/BE) studies and submit safety data at its meeting on Friday, ...
25 Jan, 2022, 05.59 AM IST
MSN to launch generic anti-COVID pill Molnupiravir under 'Molulow' brandThe group is all set to launch the generic Molnupiravir 200 mg capsules and it is being manufactured at its USFDA and MHRA accredited facil...
06 Jan, 2022, 07.01 PM IST
Britain approves Pfizer's antiviral COVID-19 pillThe approval comes as the country scrambles to build its defences amid a record hit a daily record of new COVID-19 cases on Thursday, gover...
31 Dec, 2021, 05.46 PM IST
Domestic pharma companies gear up to launch Merck's Covid pillUnion health minister Mansukh Mandaviya said 13 companies in India will manufacture the drug approved for restricted use under emergency si...
29 Dec, 2021, 07.03 AM IST
Newly infected Covid-19 patients have two new home treatment options, but there's a catchYou'll need a prescription first from a doctor or other authorized health worker.
27 Dec, 2021, 03.49 PM IST
USFDA approves COVID antiviral pill molnupiravir for emergency useThe USFDA also said the drug should be given for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or cl...
23 Dec, 2021, 08.53 PM IST
Pfizer confirms COVID pill's results, potency versus omicronThe Food and Drug Administration is expected to soon rule on whether to authorize Pfizer's pill and a competing pill from Merck, which was ...
15 Dec, 2021, 06.45 AM IST
Pill 88% effective if given early, says PfizerFinal results of Paxlovid demonstrated reduction of hospitalisation or death by 89% among high-risk patients treated within three days of s...
15 Dec, 2021, 06.28 AM IST
Expert panel asks drug cos to submit subgroup data on MolnupiravirMolnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of...
20 Nov, 2021, 12.04 AM IST
Cyndrella Carvalho's top 3 pharma picks for next 12 months“The opportunity in the Covid pill market looks significantly high. We will wait and watch in terms of how the data pans out.”
09 Nov, 2021, 04.30 PM IST
Covid pills cannot do the job alone; disease experts say there's no substitute for vaccinesThe antiviral medications stop the virus from replicating in the body.
09 Nov, 2021, 04.24 PM IST
Merck asks US FDA to authorize promising anti-COVID pillAn antiviral pill that people could take at home to reduce their symptoms and speed recovery could prove groundbreaking, easing the crushin...
11 Oct, 2021, 03.49 PM IST
Place bulk orders for Merck's Covid pillThe trials show that the pill halved the chances of hospitalisation in Covid-19 patients with mild or moderate form of the disease.
05 Oct, 2021, 11.06 PM IST
What you need to know about Merck’s new COVID treatment medicineThe pills are meant for people who are sick with COVID but are not in the hospital.
02 Oct, 2021, 04.32 PM IST
Pfizer starts large trial for anti-Covid pillIn the trial, PF-07321332, designed to block the activity of a key enzyme needed for the coronavirus to multiply, will be administered alon...
27 Sep, 2021, 08.44 PM IST